Solid Biosciences Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 |
|---|---|---|
| Operating Activities | ||
| Net Income | $-52.1M | $-21.5M |
| Depreciation & Amortization | — | — |
| Depreciation | $448.0K | $56.0K |
| Amortization | — | — |
| Stock-Based Compensation | $5.3M | $1.5M |
| Net Cash from Operating Activities | $-43.2M | $-20.1M |
| Investing Activities | ||
| Capital Expenditures | $2.3M | $392.0K |
| Business Acquisitions | — | — |
| Net Cash from Investing Activities | $10.4M | $-4.1M |
| Financing Activities | ||
| Dividends Paid | — | — |
| Stock Repurchases | — | — |
| Net Cash from Financing Activities | $77.1M | $3.4M |
| Net Change in Cash | $44.3M | $-20.8M |
| Free Cash Flow | $-45.5M | $-20.5M |